Chemiluminescence determination of chlorpheniramine using tris(1,10‐phenanthroline)–ruthenium(II) peroxydisulphate system and sequential injection analysis

A sequential injection (SI) method was developed for the determination of chlorpheniramine (CPA), based on the reaction of this drug with tris(1,10‐phenanthroline)–ruthenium(II) [Ru(phen)₃²⁺] and peroxydisulphate (S₂O₈^2–) in the presence of light. The instrumental set‐up utilized a syringe pump and a multiposition valve to aspirate the reagents [Ru(phen)₃²⁺ and S₂O₈^2–] and a peristaltic pump to propel the sample. The experimental conditions affecting the chemiluminescence reaction were systematically optimized, using the univariate approach. Under the optimum conditions linear calibration curves of 0.1–10 µg/ml were obtained. The detection limit was 0.04 µg/ml and the relative standard deviation (RSD) was always < 5%. The procedure was applied to the analysis of CPA in pharmaceutical products and was found to be free from interferences from concomitants usually present in these preparations. Copyright © 2008 John Wiley & Sons, Ltd.     

Cathodic electrochemiluminescence of acetonitrile, acetonitrile-1,10-phenanthroline and acetonitrile-ternary Eu(III) complexes at a gold electrode.

Cathodic electrochemiluminescence (ECL) behaviours of the acetonitrile, acetonitrile-1,10-phenanthroline (phen) and acetonitrile-ternary Eu(III) complex systems at a gold electrode were studied. One very weak cathodic ECL-2 at -3.5 V was observed in 0.1 mol/L tetrabutylammonium tetrafluoroborate (TBABF(4)) acetonitrile solution. When 10 mmol/L tetrabutylammonium peroxydisulphate [(TBA)(2)S(2)O(8)] was added to 0.1 mol/L TBABF(4) acetonitrile solution, another cathodic ECL-1 at -2.7 V appeared and the potential for ECL-2 was shifted from -3.5 to -3.1 V. Furthermore, ECL-2 intensity was enhanced about 20-fold. When 1 x 10(-4) mol/L phen was added to 0.1 mol/L TBABF(4) + 10 mmol/L (TBA)(2)S(2)O(8) acetonitrile solution, the ECL intensities of ECL-1 and ECL-2 were enhanced about 20-fold compared with those of 0.1 mol/L TBABF(4) + 10 mmol/L (TBA)(2)S(2)O(8) acetonitrile solution. The maximum emission peaks of ECL-1 and ECL-2 in the three systems mentioned above appeared at about 530 nm. The products obtained by electrolysing 0.1 mol/L TBABF(4) acetonitrile solution at -3.5 V for 20 min were analysed by Fourier Transform Infrared (FTIR) spectra and gas chromatography-mass spectrometry (GC-MS) and the emitter of ECL-1 and ECL-2 was identified as excited state polyacetonitrile. When ternary Eu(III) complexes were presented in 0.1 mol/L TBABF(4) + 10 mmol/L (TBA)(2)S(2)O(8) acetonitrile solution, another maximum emission peak with a narrow band centred at about 610 nm appeared in ECL-1 in addition to the maximum emission peaks at about 530 nm for ECL-1 and ECL-2. The emitter of ECL emission at 610 nm was identified as the excited states Eu(III)*. The mechanisms for cathodic ECL behaviours of the acetonitrile, acetonitrile-phen and acetonitrile-ternary Eu(III) complex systems at a gold electrode have been proposed. The extremely sharp emission bands for ternary Eu(III) complexes may have analytical potential.     

Cathodic electrochemiluminescence of the peroxydisulphate–ciprofloxacin system and its analytical applications

The cathodic electrochemiluminescence (ECL) of peroxydisulphate (S₂O₈^2?)–ciprofloxacin (CPF) system at a wax‐impregnated graphite electrode was studied. When CPF was absent, S₂O₈^2? was electrochemically reduced to sulphate free radical (SO₄^??), and dissolved oxygen absorbed on the electrode surface was reduced to protonated superoxide anion radical (HO₂^?). The HO₂^? was oxidized by SO₄^?? to produce molecular oxygen in both singlet and triplet states. Some of the singlet molecular oxygen (¹O₂) further combined through collision to be an energy‐rich precursor singlet molecular oxygen pair (¹O₂)₂. A weak ECL was produced when ¹O₂ or (¹O₂)₂ was converted to ground‐state molecular oxygen (³O₂). When CPF was present, a stronger ECL was produced, which originated from two emitting species. The main emitting species was excited state CPF (CPF*), which was produced by accepting energy from (¹O₂)₂. The other emitting species was excited singlet molecular oxygen pair [(¹O₂)₂*], which originated from the chemical oxidation of CPF by SO₄^?? and dissolved oxygen. Based on the stronger ECL phenomenon, an ECL method for the determination of either S₂O₈^2? or CPF was proposed. The proposed ECL method has been applied to the determination of CPF in pharmaceutical preparations. Copyright © 2011 John Wiley & Sons, Ltd.     

Determination of the pseudoephedrine content in pharmaceutical formulations and in biological fluids using a microbore HPLC system interfaced to a microfluidic chemiluminescence detector

A novel automated precolumn derivatization followed by separation using liquid chromatography for the determination of pseudoephedrine (PSE) by a microfluidic chemiluminescence detector has been developed. An on‐line derivatization procedure was utilized by converting PSE into a highly light emitting species in a Ru(bipy)₃²⁺‐peroxydisulphate chemiluminescence (CL) system by derivatizing it with a 1.0 M formaldehyde solution. The derivatized analyte was directly injected into a microbore high‐performance liquid chromatography (HPLC) system coupled to an on‐chip chemiluminescence detector. The newly developed highly selective, sensitive and fast HPLC‐CL method was validated and successfully applied for the analysis of PSE in pharmaceutical formulations and a human urine sample. The selectivity of the method is not only due to the HPLC separation but is also due to the highly selective detection principle of the Ru(bipy)₃²⁺‐peroxydisulphate CL system used. There was no interference observed from the common preservatives and excipients used in pharmaceutical preparations, which did not show any significant CL signal. The retention time of PSE was less than 3 min, and the detection limits and quantification limits were found to be 5.7 and 26.0 µg L^–1, respectively. Copyright © 2015 John Wiley & Sons, Ltd.